JP2024525072A - Scutellaria lateriflora抽出物とCistus x Incanus抽出物の相乗抗菌組み合わせ - Google Patents
Scutellaria lateriflora抽出物とCistus x Incanus抽出物の相乗抗菌組み合わせ Download PDFInfo
- Publication number
- JP2024525072A JP2024525072A JP2024500150A JP2024500150A JP2024525072A JP 2024525072 A JP2024525072 A JP 2024525072A JP 2024500150 A JP2024500150 A JP 2024500150A JP 2024500150 A JP2024500150 A JP 2024500150A JP 2024525072 A JP2024525072 A JP 2024525072A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cistus
- incanus
- scutellaria lateriflora
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 44
- 241000632296 Scutellaria lateriflora Species 0.000 title claims abstract description 16
- 235000000350 Cistus incanus Nutrition 0.000 title claims abstract description 15
- 241000866387 Cistus incanus Species 0.000 title claims abstract description 15
- 230000002195 synergetic effect Effects 0.000 title claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 10
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 6
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 6
- 229960003321 baicalin Drugs 0.000 claims abstract description 6
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 6
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 10
- 239000012675 alcoholic extract Substances 0.000 claims description 5
- 239000002324 mouth wash Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 3
- 229940112822 chewing gum Drugs 0.000 claims description 3
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 229940051866 mouthwash Drugs 0.000 claims description 2
- 229940112824 paste Drugs 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000011885 synergistic combination Substances 0.000 abstract description 4
- 235000002548 Cistus Nutrition 0.000 description 7
- 241000984090 Cistus Species 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000605862 Porphyromonas gingivalis Species 0.000 description 6
- 241000207929 Scutellaria Species 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000001974 tryptic soy broth Substances 0.000 description 6
- 108010050327 trypticase-soy broth Proteins 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 2
- 229940015301 baicalein Drugs 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000005915 GABA Receptors Human genes 0.000 description 1
- 108010005551 GABA Receptors Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000519996 Teucrium chamaedrys Species 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 244000005702 human microbiome Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003010 neurosedative effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000018035 | 2021-07-08 | ||
IT102021000018035A IT202100018035A1 (it) | 2021-07-08 | 2021-07-08 | ASSOCIAZIONE ANTIBATTERICA SINERGICA DI ESTRATTI DI SCUTELLARIA LATERIFLORA E DI CISTUS x INCANUS |
PCT/IB2022/056177 WO2023281381A1 (en) | 2021-07-08 | 2022-07-04 | SYNERGIC ANTIBACTERIAL COMBINATION OF SCUTELLARIA LATERIFLORA EXTRACT AND CISTUS x INCANUS EXTRACT |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024525072A true JP2024525072A (ja) | 2024-07-09 |
Family
ID=78049599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024500150A Pending JP2024525072A (ja) | 2021-07-08 | 2022-07-04 | Scutellaria lateriflora抽出物とCistus x Incanus抽出物の相乗抗菌組み合わせ |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4366752A1 (it) |
JP (1) | JP2024525072A (it) |
KR (1) | KR20240034757A (it) |
IT (1) | IT202100018035A1 (it) |
WO (1) | WO2023281381A1 (it) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6740343B2 (en) | 2001-09-17 | 2004-05-25 | Phytos, Inc. | Standardized extracts of Scutellaria lateriflora |
US20040109906A1 (en) | 2002-09-06 | 2004-06-10 | Stefan Gafner | Extract of mad-dog skullcap |
DE202005014459U1 (de) | 2005-09-13 | 2006-01-19 | Pandalis, Georgios, Dr. | Aerosol zur Vorbeugung und Behandlung der Influenza |
DE102007006122A1 (de) | 2007-02-02 | 2008-08-07 | Krewel Meuselbach Gmbh | Cistusextrakte |
DE102009011152A1 (de) * | 2009-03-05 | 2010-09-09 | Bionorica Ag | Hydrolysate aus Pflanzenextrakten sowie diese enthaltendes antibakterielles Mittel |
CN101856452A (zh) * | 2010-06-23 | 2010-10-13 | 武伟 | 一种治疗支气管炎的药物及其制备方法 |
-
2021
- 2021-07-08 IT IT102021000018035A patent/IT202100018035A1/it unknown
-
2022
- 2022-07-04 WO PCT/IB2022/056177 patent/WO2023281381A1/en active Application Filing
- 2022-07-04 KR KR1020247001589A patent/KR20240034757A/ko unknown
- 2022-07-04 EP EP22744826.3A patent/EP4366752A1/en active Pending
- 2022-07-04 JP JP2024500150A patent/JP2024525072A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4366752A1 (en) | 2024-05-15 |
KR20240034757A (ko) | 2024-03-14 |
WO2023281381A1 (en) | 2023-01-12 |
IT202100018035A1 (it) | 2023-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Furiga et al. | In vitro study of antioxidant capacity and antibacterial activity on oral anaerobes of a grape seed extract | |
Cardoso et al. | Influence of a Brazilian wild green propolis on the enamel mineral loss and Streptococcus mutans’ count in dental biofilm | |
Bin et al. | Potential effect of Allium sativum bulb for the treatment of biofilm forming clinical pathogens recovered from periodontal and dental caries | |
Teanpaisan et al. | In vitro antimicrobial and antibiofilm activity of Artocarpus lakoocha (Moraceae) extract against some oral pathogens | |
Anand et al. | Effect of oil-pulling on dental caries causing bacteria | |
González et al. | Antibacterial effects of blackberry extract target periodontopathogens | |
Bomdyal et al. | Antibacterial activity of curcumin (turmeric) against periopathogens-An in vitro evaluation | |
Smida et al. | Benefits of sea buckthorn (Hippophae rhamnoides) pulp oil‐based mouthwash on oral health | |
JP2006199661A (ja) | 共凝集阻害剤 | |
Jenner et al. | Evaluating the antimicrobial activity of commercially available herbal toothpastes on microorganisms associated with diabetes mellitus | |
Saquib et al. | Synergistic antibacterial activity of herbal extracts with antibiotics on bacteria responsible for periodontitis | |
Widyarman et al. | Antibiofilm effect of Clitoria ternatea flower juice on Porphyromonas gingivalis in vitro | |
Xi et al. | The effect of polyphenol-containing solutions on in situ biofilm formation on enamel and dentin | |
Bakhshi et al. | In vitro antibacterial effect of Pimpinella anisum essential oil on Enterococcus faecalis, Lactobacillus casei, Actinomyces naeslundii, and Aggregatibacter actinomycetemcomitans | |
Afolabi et al. | Susceptibility of cariogenic Streptococcus mutans to extracts of Garcinia kola, Hibiscus sabdariffa, and Solanum americanum. | |
Nurrahman et al. | Effectiveness of Matricaria chamomilla essential oil on Aggregatibacter actinomycetemcomitans and Treponema denticola biofilms | |
Hendiani et al. | Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of mangosteen (Garcinia mangostana Linn.) rind extract against Aggregatibacter actinomycetemcomitans | |
JP2010064961A (ja) | 口腔常在菌叢調整剤およびこれを用いた口腔常在菌叢調整方法 | |
JP2024525072A (ja) | Scutellaria lateriflora抽出物とCistus x Incanus抽出物の相乗抗菌組み合わせ | |
Demirez Bircan et al. | Comparative evaluation of various herbal extracts on biofilms of Streptococcus mutans and Scardovia wiggsiae: An in vitro study | |
Elgamily et al. | Laboratory evaluation of anti-plaque and remineralization efficacy of sugarless probiotic jelly candy supplemented with natural nano prebiotic additive | |
Ariamanesh et al. | Synergistic effect of persica mouthwash and Iranian ethanolic extract of propolis against biofilm formation of oral pathogens (in vitro study) | |
Ansiliero et al. | (Antimicrobial and antioxidant activity of hydroalcoholic extracts of bee propolis (Tetragonisca angustula) and/or Calendula officinalis and potential use in mouthwash formulation/Atividade antimicrobiana e antioxidante de extratos hidroalcoólicos de propolis de abelha (Tetragonisca angustula) e/ou Calendula officinalis e potencial uso na formulação de enxaguantes bucais | |
George et al. | Effectiveness of propolis, probiotics and chlorhexidine on Streptococcus mutans and Candida albicans: An in-vitro study | |
Safa Larijani et al. | Antimicrobial Activity of Carvacrol against Lactobacillus acidophilus and Lactobacillus casei, An In-Vitro Study |